South African biotech Afrigen Biologics has secured a $6.2m grant from the Coalition for Epidemic Preparedness Innovations (CEPI) to develop the first mRNA-based vaccine against Rift Valley fever.

Global efforts for a Rift Valley fever (RVF) vaccine accelerate as South Africa’s Afrigen Biologics begins local development of mRNA vaccine. With no vaccine approved for human use yet ...

Arizona State University's Decision Theater is developing a tool that uses AI to create an algorithm to predict when chances ...

have urged East African countries to create awareness and increase preparedness due to a potential outbreak of the Rift Valley Fever. The RVF warnings are predicted to be on the rise following the ...

A Valley fever vaccine for animals may be available by the end of the year. Dr. John Galgiani, founder of the Valley Fever ...

Residents in Hurricane are not just concerned about the inconvenience, disruption and mess of construction blasting close to ...

Valley Fever, or coccidioidomycosis, is a fungus that develops below the undisturbed surface of soils in hot, dry areas in the western United States. The fungus, when inhaled in dust, can cause ...

Other diseases that kill animals or force massive culling across geographical borders, causing losses of millions of animals and huge economic costs, include the Rift Valley fever; African swine fever ...